| Product Code: ETC9958728 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United States (US) Advanced Therapy Medicinal Products Market Overview |
3.1 United States (US) Country Macro Economic Indicators |
3.2 United States (US) Advanced Therapy Medicinal Products Market Revenues & Volume, 2021 & 2031F |
3.3 United States (US) Advanced Therapy Medicinal Products Market - Industry Life Cycle |
3.4 United States (US) Advanced Therapy Medicinal Products Market - Porter's Five Forces |
3.5 United States (US) Advanced Therapy Medicinal Products Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.6 United States (US) Advanced Therapy Medicinal Products Market Revenues & Volume Share, By Phase, 2021 & 2031F |
4 United States (US) Advanced Therapy Medicinal Products Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of chronic diseases in the US leading to the demand for advanced therapy medicinal products |
4.2.2 Growing investments in research and development for advanced therapies in the US |
4.2.3 Favorable regulatory environment supporting the development and commercialization of advanced therapy medicinal products |
4.3 Market Restraints |
4.3.1 High cost associated with advanced therapy medicinal products limiting accessibility for patients |
4.3.2 Complex manufacturing processes and stringent regulatory requirements leading to longer time to market |
4.3.3 Limited awareness among healthcare providers and patients about the benefits and availability of advanced therapy medicinal products |
5 United States (US) Advanced Therapy Medicinal Products Market Trends |
6 United States (US) Advanced Therapy Medicinal Products Market, By Types |
6.1 United States (US) Advanced Therapy Medicinal Products Market, By Product |
6.1.1 Overview and Analysis |
6.1.2 United States (US) Advanced Therapy Medicinal Products Market Revenues & Volume, By Product, 2021- 2031F |
6.1.3 United States (US) Advanced Therapy Medicinal Products Market Revenues & Volume, By Gene Therapy, 2021- 2031F |
6.1.4 United States (US) Advanced Therapy Medicinal Products Market Revenues & Volume, By Cell Therapy, 2021- 2031F |
6.1.5 United States (US) Advanced Therapy Medicinal Products Market Revenues & Volume, By Tissue Engineered, 2021- 2031F |
6.1.6 United States (US) Advanced Therapy Medicinal Products Market Revenues & Volume, By Others, 2021- 2031F |
6.2 United States (US) Advanced Therapy Medicinal Products Market, By Phase |
6.2.1 Overview and Analysis |
6.2.2 United States (US) Advanced Therapy Medicinal Products Market Revenues & Volume, By Phase I, 2021- 2031F |
6.2.3 United States (US) Advanced Therapy Medicinal Products Market Revenues & Volume, By Phase II, 2021- 2031F |
6.2.4 United States (US) Advanced Therapy Medicinal Products Market Revenues & Volume, By Phase III, 2021- 2031F |
6.2.5 United States (US) Advanced Therapy Medicinal Products Market Revenues & Volume, By Phase IV), 2021- 2031F |
7 United States (US) Advanced Therapy Medicinal Products Market Import-Export Trade Statistics |
7.1 United States (US) Advanced Therapy Medicinal Products Market Export to Major Countries |
7.2 United States (US) Advanced Therapy Medicinal Products Market Imports from Major Countries |
8 United States (US) Advanced Therapy Medicinal Products Market Key Performance Indicators |
8.1 Number of clinical trials and research studies conducted on advanced therapy medicinal products in the US |
8.2 Adoption rate of advanced therapy medicinal products by healthcare facilities and providers |
8.3 Patient outcomes and success rates following treatment with advanced therapy medicinal products |
9 United States (US) Advanced Therapy Medicinal Products Market - Opportunity Assessment |
9.1 United States (US) Advanced Therapy Medicinal Products Market Opportunity Assessment, By Product, 2021 & 2031F |
9.2 United States (US) Advanced Therapy Medicinal Products Market Opportunity Assessment, By Phase, 2021 & 2031F |
10 United States (US) Advanced Therapy Medicinal Products Market - Competitive Landscape |
10.1 United States (US) Advanced Therapy Medicinal Products Market Revenue Share, By Companies, 2024 |
10.2 United States (US) Advanced Therapy Medicinal Products Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here